Stirlingshire Investments’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$507K Sell
1,998
-408
-17% -$95.1K 0.38% 85
2026
Q1
$588K Sell
2,406
-19
-0.8% -$4.43K 0.52% 50
2025
Q4
$502K Buy
+2,425
New +$480K 0.45% 61

Other funds holding JNJ

Stirlingshire Investments's JNJ Position: Q2 2026 in Review

Stirlingshire Investments reduced its Johnson & Johnson (JNJ) stake by 17% in Q2 2026, selling an estimated $95.1K and leaving 1,998 shares worth $507K. The position accounts for 0.38% of the portfolio, ranked #85.

Stirlingshire Investments first reported a position in JNJ in Q4 2025 and has held it in 3 quarters since. The position peaked at $588K in Q1 2026. 4,672 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Stirlingshire Investments held 1,998 shares of Johnson & Johnson worth $507K as of Q2 2026.
  • Stirlingshire Investments sold 408 Johnson & Johnson shares in Q2 2026, an estimated $95.1K.
  • Johnson & Johnson made up 0.38% of Stirlingshire Investments's portfolio in Q2 2026, its #85 holding.
  • Stirlingshire Investments first reported a position in Johnson & Johnson in Q4 2025 and has held it in 3 quarters since.
  • Stirlingshire Investments's Johnson & Johnson position peaked at $588K in Q1 2026.
  • 4,672 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Stirlingshire Investments's 13F filing for Q2 2026, filed 31 Jul 2026.